IGNT THURS AFTER CLOSE NEWS!!!

[RAZOR11]

Ingen Moves Forward in $40B GSA Schedule for Military and Va Hospitals


ISO Certification to be Finalized for Export Markets

YUCAIPA, Calif., Jul 30, 2009 (GlobeNewswire via COMTEX) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading Medical Device Manufacturer focused in the $8 Billion global Respiratory Markets for the growing ageing population and emerging markets for Home (DME), Hospital and Aviation Industries, announced today that the company expects to be listed as a GSA contractor by the end of the year, and at the same time will finalize the ISO certification in order to export the new Oxyview Nasal Cannula to China, Japan, Canada and Europe.
Ingen has prepaid the fees required for the Texas based KGMA Business Solutions, Inc. to finalize the GSA Schedule 65IIA proposal for submission in August-2009. The GSA Schedule 65IIA allows Ingen to be listed under the U.S. General Services Administration as a contractor to sell medical products and services to the military and government owned VA Hospitals. With hundreds of VA Hospitals and more than 25 million veterans, the new Oxyview Nasal Cannnula will be sold into all of the respiratory departments at a contract price of $4.50 each. It is estimated that there are more than 2 million veterans prescribed home oxygen therapy. The company has already placed the new Oxyview Nasal Cannula with several VA Hospitals around the country. Projected GSA sales for Ingen are expected to be $2M annually.

Cheryl Fisher with the Texas based Emergo Group Inc. is scheduled to finalize ISO training on August 17, 2009. The International Standards Organization (ISO) required certification with manufacturers who sell products in designated countries outside the USA. Ingen is a licensed and FDA registered medical device manufacturer. ISO certification allows Ingen to market and sell the new Oxyview Nasal Cannula in China, Japan, Australia, Canada and Europe, with projected sales of $200M annually.

"Ingen will be GSA listed and ISO certified in time to launch the new Oxyview Nasal Cannula in to new government markets and world markets. This can only strengthen sales and earnings for our shareholders. The company is now preparing for a share buy-back program as a part of strengthening the share price. There are no reverse splits considered now or in the future. The shareholders must be considered first, and our products and revenues will blaze a new trail for this company," stated Scott R. Sand, Chief Financial Officer and Chairman of the Board.










About Ingen/Oxyview:

Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 Billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.

The Ingen Technologies, Inc. logo is available at

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission

[RAZOR11]

YUCAIPA, Calif., Oct. 8, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading Global Medical Device manufacturer focused in the $ 4 Billion Respiratory Market for the growing ageing and emerging markets for Home (DME), Hospital and Aviation Industries announced today that the company has signed a national 5 month campaign with The Money Channel and American Scene Radio program to reach millions of wealthy investors.


Related Quotes
Symbol Price Change
IGNT.PK 0.0038 -0.0004


{"s" : "ignt.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}
The Money Channel offers Ingen major exposure to the investment world. The program includes 12 Investor Showcase Radio segments on the American Scene radio program from now through March 31, 2010. Ingen will also be present at the World Money Show in February-2010 which will be a televised segment on Fox Business Television.



The Money Channel is one of the most successful, national Money-talk Radio programs in America. "Steve Crowley's American Scene" was launched from the Disney/MGM Radio Studios at the Walt Disney World Resort in June 1990. American Scene attracts a larger and larger radio audience every month from coast to coast. The Money Channel recently added Boston and Atlanta affiliates to our tremendous national lineup of stations. Today, The Money Channel has a national base of 3,000,000 listeners on a three-hour daily radio broadcast through the mighty IRN/USA Radio Network affiliates, plus other affiliates, and they have a growing listening audience on the Internet worldwide. This is the primary destination for Steve Crowley's insights and advice in the financial world. Plus Steve interviews all the top experts, analysts, money managers and authors covering stocks, investments, business, the economy and trends, Small-Cap CEOs and much more. More than 200 Financial "Stars" are interviewed in constant rotation....from Steve Forbes to Tobin Smith to Beth Dater to Joe Battipaglia. No other Money-talk Radio Program in America even comes close to this level of credible content.



"I have worked with Steve Crowley over the past several years, and The Money Channel and American Scene Radio have been very effective in the ability to introduce Ingen Technologies to a large group of wealthy investors. Ingen is performing very well with sales, operations, and projected growth trends. The company is at its reflex point, and projections for 2010 include revenues over $10M, several new Oxyview products, a decrease in manufacturing costs and an increase in margins, as well as an increase in earnings," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.

[Chuck.W]

Great news after close yesterday. Keep watching this on.

[trading_guy]

I think IGNT is gonna do great today!! Also keep your eyes on TCHH for possible run!!

[ErroneousJ]

https://charts.edgar-online.com/ext/...6A-HO:SW-BT=11

[ErroneousJ]

Ingen Technologies brings over 20 years of experience and dedication to the design and support of medical devices, Ingen has helped many medical professionals meet clinical and economic objectives.

Ingen has developed medical products that provide a valuable benefit to the patient and cost savings to the insurance companies, Medicare and essentially the tax payer. The medical products provide a focus for the ever-increasing elderly population. These products are superior to any of our competition and they allow for effective medical product availability to seniors.
Ingen

[ErroneousJ]

IGNT Cuts Manufacturing Costs and Increases Its Margins
Click Here to Read the Featured Report about this Company

YUCAIPA, Calif., Oct. 14, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News ), a leading Global Medical Device manufacturer focused in the $4 billion Respiratory Market for the growing ageing and emerging markets for Home (DME), Hospital and Aviation Industries, announced today that the company has received a proposal from a leading manufacturer to help reduce production costs and material costs by 50% for the manufacture of the Oxyview and the Oxyview Nasal Cannula.

As a part of improving product quality in large production, and reducing material and production costs to be more competitive in the respiratory marketplace, the company has received a proposal from a leading respiratory equipment manufacturer based in Pomona-California. The company CEO, and some of the management staff received a proposal on Wednesday last week to manufacture both the Oxyview and the Oxyview Nasal Cannula at 50% of the original costs from its current manufacturer and supplier. On Friday last week, they had a meeting in Pomona with the new manufacturer to discuss the new manufacturing and distribution of Oxyview and the new Oxyview Nasal Cannula.

"Now that we are selling our respiratory products, and sales have escalated, we must reduce our cost of goods sold in order to increase our profit margins and decrease the costs to our dealers and buyers. This change will give the company a stronger foot-hold in the market. We have a proprietary product and there is nothing in the marketplace that can compete with our device. We have gained support for all sectors of our industry, inclusive of leading respiratory equipment manufacturers, clinical foundations and more important, our shareholders," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.


Click Here to Read the Featured Report about this Company

[Chuck.W]

Making big moves. Time to get in